https://www.zacks.com/stock/news/2193150/reasons-why-retaining-transunion-tru-can-be-a-wise-decision?cid=CS-ZC-FT-analyst_blog|rank_focused-2193150
Dec 04, 2023 - TransUnion (TRU) is gaining from transformation initiatives, acquisitions and collaborations. Competition is concerning.
zc:702146080268921194
0
https://www.zacks.com/stock/news/2194216/reasons-why-you-should-retain-wex-in-your-portfolio-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2194216
Dec 06, 2023 - WEX's organic growth, strategic acquisitions and customer-centric approach drive revenues. The recent Payzer acquisition aligns with its expansion strategy.
zc:-8674276363036421359
0
https://www.zacks.com/stock/news/2195167/docusign-docu-reports-q3-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2195167
Dec 07, 2023 - Although the revenue and EPS for DocuSign (DOCU) give a sense of how its business performed in the quarter ended October 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-3254107620799683757
0
https://www.zacks.com/stock/news/2197532/earnings-estimates-rising-for-docusign-docu-will-it-gain?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2197532
Dec 13, 2023 - DocuSign (DOCU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zc:5324651420870457324
0
https://www.zacks.com/stock/news/2198602/uipath-inc-path-hit-a-52-week-high-can-the-run-continue?cid=CS-ZC-FT-52_week_high-2198602
Dec 15, 2023 - UiPath (PATH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
zc:-1517816347885927177
0
https://www.zacks.com/stock/news/2205732/here-s-why-fiserv-fi-stock-is-an-attractive-pick-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205732
Jan 04, 2024 - Fiserv (FI) banks on its increasing current ratio and increasing return on assets while being committed to returning value to shareholders.
zc:-6669315816716303303
0
https://www.zacks.com/stock/news/2206508/here-s-why-docusign-docu-is-an-attractive-pick-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2206508
Jan 05, 2024 - DocuSign (DOCU) banks on its increasing current ratio and increasing return on assets while being committed to returning value to shareholders.
zc:617661517091188599
0
https://www.zacks.com/commentary/2207678/3-top-ranked-stocks-to-buy-for-high-growth?cid=CS-ZC-FT-investment_ideas-2207678
Jan 09, 2024 - Some investors prefer to reap a steady income stream or target value. But for those seeking high-growth, these three companies fit the criteria nicely.
zc:4240338949568745155
0
https://www.zacks.com/stock/news/2215110/booz-allen-bah-invests-in-albedo-for-vleo-satellite-imaging?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2215110
Jan 24, 2024 - Booz Allen (BAH) invests strategically in Albedo, the first to operate satellites in very low earth orbit (VLEO), advancing ultra-high resolution commercial imagery for diverse applications.
zc:3098347758065451324
0
https://www.zacks.com/stock/news/2219004/robert-half-s-rhi-q4-earnings-beat-estimates-decline-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2219004
Jan 31, 2024 - Robert Half's (RHI) fourth-quarter 2023 revenues decrease year over year.
zc:-7270268543237340839
0